In recent years, the scientific community has turned its attention back to the potential of psychedelics as therapeutic agents, with psilocybin, a naturally occurring substance found in certain mushrooms, at the forefront of this research. A new study published in the journal Molecular Psychiatry suggests possible benefits of using psilocybin-containing mushroom extract over its chemically synthesized counterpart for the treatment of psychiatric disorders such as depression, PTSD, obsessive-compulsive disorders, and anxiety. “My colleagues and I are very interested in the potential of psychede…